Introduction
============

A growing body of data indicates that 10%--20% of bereaved persons develop a form of inordinate, prolonged grief, variously referred to as complicated grief (CG), prolonged grief disorder, or traumatic grief and it is included among "disorders requiring further research" in *Diagnostic and Statistical Manual of Mental Disorders*, 5th edition (DSM-5) under the name of Persistent Complex Bereavement Disorder.[@b1-ndt-11-2583]--[@b4-ndt-11-2583]

Symptoms of CG include yearning and longing for the deceased, with intense sorrow and painful emotions persisting more than 1 year after the loss. Patients show preoccupation with the deceased and with the circumstances of the death and may have recurrent, intrusive images or thoughts of the death, may feel a sense of disbelief and may avoid reminders of the deceased. In addition, subjects with CG may feel that life is meaningless or empty without the deceased and they may desire to die in order to be reunited with the deceased.[@b5-ndt-11-2583]--[@b10-ndt-11-2583]

Several studies suggest that CG impacts uniquely on physical and mental health, increasing the risk for suicidal ideation, substance abuse, chronic medical conditions, and impaired global functioning.[@b11-ndt-11-2583]--[@b17-ndt-11-2583] Specifically, an association between CG symptoms and the risk of developing cardiac problems has been suggested.[@b11-ndt-11-2583] However, to the best of our knowledge, only one study evaluated CG symptoms among subjects with heart diseases. In this report, poorer physical and mental health outcomes were found among patients who had undergone coronary artery bypass grafts with concurrent CG compared to those without CG.[@b18-ndt-11-2583]

The purpose of this study is to investigate bereavement among inpatients admitted for an acute coronary syndrome (ACS) with no previous history of coronary heart disease (CHD) and to evaluate whether symptoms of CG may have an impact on ACS outcomes and/or physical and mental health-related quality of life.

Methods
=======

Sample
------

Patients with ACS and no previous history of CHD who were admitted to three cardiac intensive care units (CICUs) were eligible for inclusion if they met the criteria for either acute myocardial infarct with ST-segment elevation or without ST-segment elevation or unstable angina, verified by standard ACS criteria. Additional details about study sample and methods have been published elsewhere.[@b19-ndt-11-2583],[@b20-ndt-11-2583]

The three units were located in a northwest area of Italy, with an average distance of 40 miles from each other and serving similar geographic catchment areas in terms of sociodemographic characteristics. Exclusion criteria were the presence of neoplastic disease, severe pulmonary, hepatic, or renal insufficiency, infections requiring antibiotics, autoimmune disease, immunosuppressive therapy, severe anemia, and severe degenerative disease of the central nervous system. The study protocol was approved, according to Declaration of Helsinki, by the University of Pisa and ASL-5 ethics committees, and written informed consent was obtained from all patients.

Cardiological evaluation
------------------------

Data on patients' demographics, medical history, clinical characteristics, electrocardiographic findings, ACS definition and treatment interventions, as well as in-hospital outcomes were reported in a detailed standardized case record form, adapted from the Blitz study,[@b20-ndt-11-2583] by a trained cardiologist in each CICU. The details on symptoms onset, first medical help seeking, and arrival at hospital CICU were collected as soon as patients could be interviewed. Particular care was taken in assessing the timing of arrival at hospital CICU, ECG execution, and reperfusion treatment. Additional items included length of stay in the CICU and overall hospital stay, timing of invasive procedures, and transfer to a tertiary care hospital to undergo coronary angiography and/or revascularization.

Risk factors evaluation
-----------------------

All subjects were assessed at the time of enrollment for the following measures: resting blood pressure and cardiovascular risk factors, including tobacco smoking, diabetes mellitus, and hypertension. Hypertension was defined as either resting systolic or diastolic blood pressure greater than or equal to 140/90 mmHg at two different times or being on antihypertensive medications. Diabetes mellitus was defined as a serum fasting glucose level greater than or equal to 7.1 mmol/L or being on hypoglycemic medications.

Psychiatric assessment
----------------------

The severity of CG symptoms was investigated by the Structured Clinical Interview for Complicated Grief (SCI-CG), a 33-item semi-structured interview assessing the presence or absence of symptoms associated with CG, as well as details surrounding the death of a loved one.[@b21-ndt-11-2583],[@b22-ndt-11-2583]

The presence and severity of current depression were assessed by the 17-item Hamilton Depression Rating Scale (HAM-D).[@b23-ndt-11-2583] The HAM-D provides an indication of depression and, over time, a guide to recovery. It is widely used to provide accepted outcome measures for evaluating the severity of depression symptoms in ACS patients. Eight items are scored on a 5-point scale, ranging from 0= not present to 4= severe. Nine items are scored from 0 to 2. Scores of 5 or below define the absence of clinically relevant depression; scores between 6 and 13 indicate mild depression; scores from 14 to 18 indicate moderate depression; and scores of 19 and above indicate severe depression.[@b24-ndt-11-2583]

The severity of anxiety symptoms was evaluated by means of the Hamilton Anxiety Rating Scale (HAM-A).[@b25-ndt-11-2583] The scale comprises 14 items, exploring both psychic and somatic anxiety. Each item is scored on a 5-point scale, ranging from 0 (not present) to 4 (severe), where a total score below 17 indicates mild anxiety, a score between 18 and 24 indicates mild-to-moderate anxiety, and scores from 25 and above indicate moderate-to-severe anxiety.

The 36-item Short-Form Health Survey (MOS-SF-36)[@b26-ndt-11-2583] was used to assess general health status. The measure comprises 36 items within the following eight subscales: "physical functioning" (extent to which health limits physical activities), "role physical" (extent to which physical health interferes with work or other daily activities), "bodily pain" (intensity of pain and effect on normal work), "general health" (personal evaluation of health, current and outlook), "vitality" (feeling energetic), "social functioning" (extent to which physical health or emotional problems interfere with normal social activities), "role emotional" (extent to which emotional problems interfere with work or other daily activities), and "mental health" (general mental health, including depression, anxiety, behavioral and emotional control, general positive affect). The first four subscales comprise the physical component summary score, while the other four subscales comprise the mental component summary score. Subscale raw scores are standardized and range between 0 and 100, where 0 is the worst and 100 the best possible health status.[@b27-ndt-11-2583]

Statistical analyses
--------------------

Significant differences between subjects who lost a parent/a sibling/a partner and those who lost another relative were evaluated by two-tailed *t*-tests for continuous measures and by *χ*^2^-tests for categorical variables.

In order to evaluate the health consequences associated with CG, SCI-CG scores were used to predict the various health outcomes. Continuous outcomes (ie, age at index ACS, the number of days spent in the CICU, and MOS-SF-36 domain scores) were analyzed using a series of multiple regressions. In each of these analyses, health outcomes were regressed on the SCI-CG score while controlling for age, sex, and cardiovascular risk factors (tobacco smoking, diabetes mellitus, and hypertension).

Dichotomous dependent variables (eg, presence/absence of single ACS risk factors) were analyzed by a series of logistic regressions. Each model estimated the effects of SCI-CG score on a single dichotomous health outcome while controlling for age, sex, and cardiovascular risk factors.

Comparisons were considered statistically significant at the 0.05 level (*P*≤0.05). Analyses were conducted using SPSS, version 20 (IBM Corporation, Armonk, NY, USA).[@b28-ndt-11-2583]

Results
=======

Overall, 149 subjects with ACS and with no previous history of CHD were recruited. Among them, 118 (79.2%) had experienced the death of a loved one and met the criteria for DSM-5 persistent complex bereavement disorder. The 118 bereaved included in the analyses did not differ from the rest of total group in terms of sex, age, CHD risk factors, HAM-D, HAM-A, SCI-CG total scores, or MOS-SF-36 domain scores (data not shown here).

Demographical and clinical characteristics of bereaved subjects dichotomized by relationship to the deceased (partner/child/sibling vs parent/other relatives) are shown in [Table 1](#t1-ndt-11-2583){ref-type="table"}.

Subjects who lost a partner, a child, or a sibling were older (*P*=0.008) and less likely to be working (*P*=0.032) than those without such losses. They showed significantly greater scores on the SCI-CG (*P*=0.001) and were more likely to have developed the index ACS between 12 and 48 months after the death than those who lost a parent or another relative (*P*≤0.0001). The two groups did not differ on outcomes of current ACS. However, subjects who lost a partner, a child, or a sibling were more likely to have been diagnosed with hypertension (*P*=0.021) than those who lost a parent or another relative.

[Table 2](#t2-ndt-11-2583){ref-type="table"} demonstrates linear and logistic regression models in which SCI-CG score served as predictor of various clinical correlates in the overall sample of bereaved subjects with ACSs.

Controlling for age, sex, and CHD risk factors, mean SCI-CG scores were correlated with the occurrence of the ACS between 12 and 48 months (*P*=0.019) and inversely correlated with the onset of the ACS more than 48 months after the loss (*P*=0.005). Moreover, SCI-CG scores significantly predicted lower scores on the "general health" domain of MOS-SF-36 (*P*=0.030), as well as lower scores on "emotional well-being" domain (*P*=0.010) controlling for age, sex, HAM-D and HAM-A scores.

Discussion
==========

This study aimed at exploring bereavement and CG symptoms among subjects with no history of CHD at the time of a first ACS and at evaluating the impact of CG symptoms on ACS correlates and health status. We found that the majority (79.2%) of individuals with a recent ACS had experienced the death of a loved one and had presented symptoms of persistent complex bereavement disorder. Interestingly, while bereavement itself was not associated with specific sociodemographic and clinical characteristics, some differences emerged with respect to association between the loss and some clinical variables preceding ACS. In fact, the loss of a close relative (namely, a partner, a child, or a sibling) was associated with the presence of hypertension and with worse health status with respect to the loss of a parent or other relative. Moreover, while the majority of subjects, independently from the relationship to the deceased, had developed the index ACS more than 48 months after the death, a significantly higher proportion (approximately one in five) of individuals who lost a close relative had developed the index ACS between 12 and 48 months after the death. In addition, they had higher levels of CG symptoms than subjects who lost a parent or other relative. The fact that that the nature and quality of the relationship between the subjects and their deceased relative were not measured limits the interpretation of these associations. However, the finding of higher levels of CG among closely related people as partner, siblings, and children is consistent with several data from the literature. The loss of a child is among the most distressing experiences in life.[@b29-ndt-11-2583],[@b30-ndt-11-2583] Bereaved parents have been recently found to have more severe CG than those who have suffered another loss.[@b22-ndt-11-2583] In two previous investigations conducted in the general population, the loss of a spouse or a child was shown to heighten the risk of developing CG.[@b31-ndt-11-2583],[@b32-ndt-11-2583] Moreover, in another population-based study of bereaved adults who had lost a brother or a sister to cancer, the majority of subjects had not worked through their grief over the sibling's death after 2--9 years.[@b33-ndt-11-2583]

Another important finding is that, in the overall sample of bereaved subjects, after controlling for effect of age, sex, and ACS risk factors, severity of CG symptoms was positively correlated with the occurrence of the ACS between 12 and 48 months, and inversely correlated with the occurrence of the ACS later than 48 months after the death of a closely related person.

Our results are commensurate to those of Ghesquiere et al[@b18-ndt-11-2583] the only previous study, to our knowledge, to examine CG in a population with coronary artery disease. The authors found that 90% of depressed participants had experienced the death of a loved one. A positive CG-screen was associated with more severe depression, poorer mental health related quality of life, lower social support, higher tobacco use, increased use of antidepressant medication, and poorer disease-specific physical functioning. Adding to previous longitudinal data showing that CG symptoms might be chronologically related to the development of cardiac problems,[@b11-ndt-11-2583] our findings seem to indicate a "time frame" in which the severity of CG is more likely to be associated to the index ACS. Interestingly, 12 months is precisely the time lapse that discriminates normal grief from persistent grief. In fact, in the DSM-5, persistent complex bereavement disorder is diagnosed only if at least 12 months (6 months in children) have elapsed since the death of someone with whom the bereaved had a close relationship (Criterion A).[@b4-ndt-11-2583] Within this framework, our data suggest that the severity of pathological reaction rather than physiological grief symptoms could have an impact on facilitating the onset of the ACS. Finally, the severity of CG symptoms was found to be significantly associated to poor health status, as evaluated by the MOS-SF-36. The association was significant for emotional well-being, after controlling for both anxiety and depressive symptom severity. This finding corroborates previous data indicating that CG, despite being highly comorbid with depression, may impact on quality of life independently of concomitant depressive symptoms.[@b9-ndt-11-2583],[@b34-ndt-11-2583]--[@b36-ndt-11-2583] It is also noteworthy that CG symptoms demonstrated a negative impact on MOS-SF-36 "general health," even when the presence of diabetes and hypertension were controlled for.

Several limitations need to be acknowledged in presenting our findings. First, we included subjects with no previous history of CHD and who were hospitalized at their first ACS, which may reduce the generalizability of our results. Second, the study sample was relatively small, with a small number of patients in the group of subjects who lost a close relative; thus, some comparisons with respect to kinship to the deceased may have been significant with a larger sample. Notwithstanding, it should also be kept in mind that psychiatric assessments of ACS patients, especially in relation to loss events, is not straightforward because of the patient's objective physical status. It is possible that there was not sufficient power to detect meaningful impacts of CG symptoms on some health variables. For example, a previous study found a strong correlation between CG and increased consequent tobacco smoking,[@b37-ndt-11-2583] an association that we failed to find in our study. Analogously, potential limited power imposes cautiousness in interpreting results of regression analyses, where multiple suitable explanatory variables were used. Third, although depression and anxiety symptoms were investigated, the study lacked a complete psychiatric evaluation, thus our findings could also be related to other, unmeasured confounders, such as other concurrent mental disorders.

Our data suggest a temporal relationship between CG and the occurrence of the first acute coronary episode. The differential temporal effect of grief in our sample (ie, 12--48 months vs \>48 months) stimulates further research to develop preventive interventions for cardiovascular patients and investigate potential effects of CG on endothelial/vascular parameters connected to occurrence of ACSs.

Financial support for conducting the research was provided by the Fondazione CARISPE, La Spezia, Italy.

**Disclosure**

The authors report no conflicts of interest in this work.

###### 

Demographic and clinical characteristics of 118 individuals with no previous history of CHD admitted for index ACS to three CICUs dichotomized by relationship to the deceased

  Characteristic                                                                                                                  Lost partner/child/sibling (n=23)   Lost parent/other (n=95)   *χ*/*t*   *P*-value
  ------------------------------------------------------------------------------------------------------------------------------- ----------------------------------- -------------------------- --------- -----------
  Age[c](#tfn3-ndt-11-2583){ref-type="table-fn"}                                                                                  64.1 (9.4)                          57.7 (9.8)                 −2.690    0.008
  Female sex[b](#tfn2-ndt-11-2583){ref-type="table-fn"}                                                                           4 (17.4)                            17 (17.9)                  --        1
  Years of education[c](#tfn3-ndt-11-2583){ref-type="table-fn"}                                                                   9.5 (4.3)                           10.9 (3.7)                 1.458     0.148
  Working                                                                                                                         9 (39.1)                            62 (65.3)                  5.277     0.032
  Time between death and ACS \<12 months[a](#tfn1-ndt-11-2583){ref-type="table-fn"},[b](#tfn2-ndt-11-2583){ref-type="table-fn"}   1 (4.3)                             8 (8.4)                    --        0.686
   12--48 months[a](#tfn1-ndt-11-2583){ref-type="table-fn"},[b](#tfn2-ndt-11-2583){ref-type="table-fn"}                           5 (21.7)                            3 (3.2)                    --        0.007
   More than 48 months[a](#tfn1-ndt-11-2583){ref-type="table-fn"},[b](#tfn2-ndt-11-2583){ref-type="table-fn"}                     17 (73.9)                           83 (87.4)                  --        0.100
  SCI-CG score[c](#tfn3-ndt-11-2583){ref-type="table-fn"}                                                                         47.7 (13.9)                         35.7 (6.9)                 −3.978    0.001
  HAM-D score[c](#tfn3-ndt-11-2583){ref-type="table-fn"}                                                                          5.3 (4.3)                           4.9 (5.0)                  −0.539    0.591
  HAM-A score[c](#tfn3-ndt-11-2583){ref-type="table-fn"}                                                                          5.8 (4.0)                           5.1 (5.0)                  −0.615    0.540
  Diabetes[b](#tfn2-ndt-11-2583){ref-type="table-fn"}                                                                             6 (26.1)                            11 (11.6)                  3.161     0.097
  Smoking[b](#tfn2-ndt-11-2583){ref-type="table-fn"}                                                                              14 (4.3)                            56 (55.8)                  0.013     1
  Hypertension[b](#tfn2-ndt-11-2583){ref-type="table-fn"}                                                                         17 (73.9)                           44 (46.3)                  5.648     0.021
  STEMI[b](#tfn2-ndt-11-2583){ref-type="table-fn"}                                                                                16 (69.6)                           63 (66.3)                  0.010     1
  NSTEMI[b](#tfn2-ndt-11-2583){ref-type="table-fn"}                                                                               7 (30.4)                            24 (25.3)                  0.177     0.793
  Unstable angina[b](#tfn2-ndt-11-2583){ref-type="table-fn"}                                                                      0 (0)                               5 (5.3)                    --        0.581
  Days spent in the CICU[c](#tfn3-ndt-11-2583){ref-type="table-fn"}                                                               3.8 (2.6)                           5.4 (5.4)                  1.351     0.179
  SF-36 physical functioning                                                                                                      45.0 (41.2)                         46.9 (32.9)                0.205     0.839
   Role physical[c](#tfn3-ndt-11-2583){ref-type="table-fn"}                                                                       64.1 (46.1)                         75.3 (41.6)                −0.845    0.400
   Role emotional[c](#tfn3-ndt-11-2583){ref-type="table-fn"}                                                                      64.1 (46.1)                         75.3 (41.6)                0.855     0.396
   Energy--fatigue[c](#tfn3-ndt-11-2583){ref-type="table-fn"}                                                                     52.6 (15.6)                         58.8 (17.0)                1.582     0.116
   Emotional well-being[c](#tfn3-ndt-11-2583){ref-type="table-fn"}                                                                60.9 (15.6)                         66.9 (17.2)                1.523     0.130
   Social functioning[c](#tfn3-ndt-11-2583){ref-type="table-fn"}                                                                  64.7 (27.1)                         71.4 (27.5)                1.064     0.289
   Pain[c](#tfn3-ndt-11-2583){ref-type="table-fn"}                                                                                78.3 (19.9)                         71.5 (23.9)                −1.260    0.210
   General health[c](#tfn3-ndt-11-2583){ref-type="table-fn"}                                                                      51.0 (19.6)                         57.8 (16.4)                1.709     0.090

**Notes:**

Fisher's exact test;

N (%);

Mean (standard deviation).

**Abbreviations:** CHD, coronary heart disease; ACS, acute coronary syndrome; CICU, cardiac intensive care unit; SCI-CG, structured clinical interview for complicated grief; HAM-D, Hamilton depression rating scale; HAM-A, Hamilton anxiety rating scale; STEMI, with ST-segment elevation; NSTEMI, without ST-segment elevation.

###### 

Unstandardized regression coefficients and ORs for predictors of mental and physical health outcomes for bereaved persons with index ACS

  Dependent variable                                                       Independent variable: SCI-CG score                                                                                   
  ------------------------------------------------------------------------ ------------------------------------ ------- ------ ------------ --------------------------------------------------- -------
  Diabetes[a](#tfn5-ndt-11-2583){ref-type="table-fn"}                      −0.014                               0.033   0.99   0.93--1.05   1.606[b](#tfn6-ndt-11-2583){ref-type="table-fn"}    0.682
  Smoking[a](#tfn5-ndt-11-2583){ref-type="table-fn"}                       0.040                                0.025   1.04   0.99--1.09   16.266[b](#tfn6-ndt-11-2583){ref-type="table-fn"}   0.112
  Hypertension[a](#tfn5-ndt-11-2583){ref-type="table-fn"}                  0.005                                0.022   1.01   0.96--1.05   14.723[b](#tfn6-ndt-11-2583){ref-type="table-fn"}   0.817
  APA[a](#tfn5-ndt-11-2583){ref-type="table-fn"}                           −0.030                               0.037   0.97   0.90--1.04   1.771[b](#tfn6-ndt-11-2583){ref-type="table-fn"}    0.412
  Beta-blockers[a](#tfn5-ndt-11-2583){ref-type="table-fn"}                 −0.013                               0.035   0.99   0.92--1.06   0.210[b](#tfn6-ndt-11-2583){ref-type="table-fn"}    0.704
  ACE-inibitors[a](#tfn5-ndt-11-2583){ref-type="table-fn"}                 −0.004                               0.028   0.99   0.94--1.05   7.928[b](#tfn6-ndt-11-2583){ref-type="table-fn"}    0.881
  Statins[a](#tfn5-ndt-11-2583){ref-type="table-fn"}                       −0.006                               0.038   0.99   0.92--1.07   5.385[b](#tfn6-ndt-11-2583){ref-type="table-fn"}    0.867
  Time between death and ACS[c](#tfn7-ndt-11-2583){ref-type="table-fn"}                                                                                                                         
   Less than 12 months[c](#tfn7-ndt-11-2583){ref-type="table-fn"}          0.025                                0.034   1.03   0.96--1.10   4.863[b](#tfn6-ndt-11-2583){ref-type="table-fn"}    0.457
   Between 12 and 48 months[c](#tfn7-ndt-11-2583){ref-type="table-fn"}     0.145                                0.062   1.16   1.02--1.31   10.249[b](#tfn6-ndt-11-2583){ref-type="table-fn"}   0.019
   More than 48 months[c](#tfn7-ndt-11-2583){ref-type="table-fn"}          −0.084                               0.030   0.92   0.87--0.98   10.872[b](#tfn6-ndt-11-2583){ref-type="table-fn"}   0.005
  Age at index ACS[d](#tfn8-ndt-11-2583){ref-type="table-fn"}              0.102                                0.104   --     --           0.022[e](#tfn9-ndt-11-2583){ref-type="table-fn"}    0.331
  Days spent in the CICU[f](#tfn10-ndt-11-2583){ref-type="table-fn"}       −0.035                               0.054   --     --           0.072[e](#tfn9-ndt-11-2583){ref-type="table-fn"}    0.521
  SF-36 physical functioning[f](#tfn10-ndt-11-2583){ref-type="table-fn"}   0.044                                0.350   --     --           0.086[e](#tfn9-ndt-11-2583){ref-type="table-fn"}    0.901
   Role physical[f](#tfn10-ndt-11-2583){ref-type="table-fn"}               −0.692                               0.403   --     --           0.044[e](#tfn9-ndt-11-2583){ref-type="table-fn"}    0.088
   Role emotional[g](#tfn11-ndt-11-2583){ref-type="table-fn"}              −0.567                               0.532   --     --           0.267[e](#tfn9-ndt-11-2583){ref-type="table-fn"}    0.291
   Energy--fatigue[g](#tfn11-ndt-11-2583){ref-type="table-fn"}             −0.263                               0.156   --     --           0.286[e](#tfn9-ndt-11-2583){ref-type="table-fn"}    0.094
   Emotional well-being[g](#tfn11-ndt-11-2583){ref-type="table-fn"}        −0.345                               0.132   --     --           0.500[e](#tfn9-ndt-11-2583){ref-type="table-fn"}    0.010
   Social functioning[g](#tfn11-ndt-11-2583){ref-type="table-fn"}          −0.211                               0.254   --     --           0.280[e](#tfn9-ndt-11-2583){ref-type="table-fn"}    0.408
   Pain[h](#tfn12-ndt-11-2583){ref-type="table-fn"}                        −0.017                               0.241   --     --           0.072[e](#tfn9-ndt-11-2583){ref-type="table-fn"}    0.093
   General health[h](#tfn12-ndt-11-2583){ref-type="table-fn"}              −0.389                               0.177   --     --           0.074[e](#tfn9-ndt-11-2583){ref-type="table-fn"}    0.030

**Notes:**

SCI-CG score, age, sex simultaneously entered as independent variables in the linear regression model.

*χ*^2^ values.

SCI-CG score, age, sex, antihypertensive treatment simultaneously entered as independent variables in the linear regression model.

SCI-CG score, age, sex, smoking, beta-blockers use, simultaneously entered as independent variables in the linear regression model.

*R*^2^ values.

SCI-CG score, hypertension, diabetes, age, sex, simultaneously entered as independent variables in the linear regression model.

SCI-CG score, HAM-D, HAM-A, age, sex, simultaneously entered as independent variables in the linear regression model.

SCI-CG score, hypertension, smoking, diabetes, sex, simultaneously entered as independent variables in the linear regression model.

**Abbreviations:** SE, standard error of mean; ORs, odds ratios; ACS, acute coronary syndrome; APA, anti platelet agent; SCI-CG, structured clinical interview for complicated grief; CICU, cardiac intensive care unit; HAM-D, Hamilton depression rating scale; HAM-A, Hamilton anxiety rating scale.
